GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewon Pharmaceutical Co Ltd (XKRX:003220) » Definitions » Ending Cash Position

Daewon Pharmaceutical Co (XKRX:003220) Ending Cash Position : ₩14,601 Mil (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Daewon Pharmaceutical Co Ending Cash Position?

Daewon Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩14,601 Mil.

Daewon Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2024 (₩15,703 Mil) to Dec. 2024 (₩17,057 Mil) but then declined from Dec. 2024 (₩17,057 Mil) to Mar. 2025 (₩14,601 Mil).

Daewon Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2022 (₩26,970 Mil) to Dec. 2023 (₩29,982 Mil) but then declined from Dec. 2023 (₩29,982 Mil) to Dec. 2024 (₩17,057 Mil).

Daewon Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Daewon Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewon Pharmaceutical Co Ending Cash Position Chart

Daewon Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,439.09 41,697.12 26,969.83 29,982.40 17,056.79

Daewon Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32,415.42 19,581.26 15,702.81 17,056.79 14,600.72

Daewon Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Daewon Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=29982.404+-12925.612
=17,057

Daewon Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=17056.792+-2456.069
=14,601

Daewon Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Daewon Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Daewon Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewon Pharmaceutical Co Ltd (XKRX:003220) » Definitions » Ending Cash Position
Comparable Companies
XKRX:243070 XKRX:033270 XKRX:067080 XKRX:256840 XKRX:000520 XKRX:003000 XKRX:176750 XKRX:389470 XKRX:476060 XKRX:249420 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
229-3 Yongdap-dong, Seongdong-gu, Seoul, KOR, 133-850
Website
https://www.daewonpharm.com
Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.

Daewon Pharmaceutical Co Headlines

No Headlines